1. |
WILLEMZE R, JAFFE ES, BURG G, et al. WHOEORTC classification for cutaneous lymphomas[J]. Blood,2005,105(10):37683785.
|
2. |
张冬梅,路建新,沈爱国,等.P27kip1与细胞周期素D3在非霍奇金淋巴瘤中的表达、定位及相互关系[J].中华血液学杂志,2005,26(12):723727.
|
3. |
MOLLER MB, NIELSEN O, PEDERSEN NT. Cyclin D3 expression in nonHodgkin lymphoma. Correlation with other cell cycle regulators and clinical features[J]. Am J Clin Pathol,2001,115(3):404412.
|
4. |
GLOGHINI A, GAIDANO G, LAROCCA LM, et al. Expression of cyclindependent kinase inhibitor p27 (Kip1) in AIDSrelated diffuse largecell lymphomas is associated with EpsteinBarr virusencoded latent membrane protein 1[J]. Am J Pathol,2002,161(1):16371.
|
5. |
KIM DH, LEE HI, NAM ES, et al. Reduced expression of the cellcycle inhibitor p27Kip1 is associated with progression and lymph node metastasis of gastric carcinoma[J]. Histopathology,2000,36(3):245251.
|
6. |
SHIN JY, KIM HS, PARK J, et al. Mechanism for inactivation of the KIP family cyclindependent kinase inhibitor genes in gastric cancer cells[J]. Cancer Res,2000,60(2):262265.
|
7. |
LLOYD RV, ERICKSON LA, JIN L, et al. p27kip1: a multifunctional cyclindependent kinase inhibitor with prognostic significance in human cancers[J]. Am J Pathol,1999,154(2):313323.
|
8. |
TAN P, CADY B, WANNER M, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas[J]. Cancer Res,1997,57(7):12591263.
|
9. |
ESPOSITO V, BALDI A, DE LUCA A, et al. Prognostic role of the cyclindependent kinaseinhibitor p27 in nonsmall cell lung cancer[J]. Cancer Res,1997,57(16):33813385.
|
10. |
SANCHEZBEATO M, CAMACHO FI, MARTINEZMONTERO JC, et al. Anomalous high p27/KIP1expression in a subset of aggressive Bcell lymphomas is associated with cyclin D3 overexpression. p27/KIP1cyclin D3 colocalization in tumor cells[J]. Blood,1999,94(2):765772.
|
11. |
QUINTANILLAMARTINEZ L, THIEBLEMONT C, FEND F, et al. Mantle cell lymphoma lack expression of p27kip1, a cyclindependent kinase inhibitor[J]. Am J Pathol,1998,153(1):175182.
|
12. |
MOREIRA JúNIOR G, COLLEONI GW, CANGI MG, et al. Reciprocal Cdc25A and p27 expression in Bcell nonHodgkin lymphomas[J]. Diagn Mol Pathol,2003,12(3):128132.
|
13. |
KANGDECKER N, TONG C, BOUSSOUAR F, et al. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency[J]. Cancer Cell,2004,5(2):177189.
|
14. |
VEGA F, CHANG CC, MEDEIROS LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles[J]. Modern Pathol,2005,18(6):806815.
|
15. |
NAKAYAMA KI, HATAKEYAMA S, NAKAYAMA K. Regulation of the cell cycle at the G1S transition by proteolysis of cyclin E and p27Kip1[J]. Biochem Biophys Res Commun,2001,282(4):853860.
|
16. |
CHIARLE R, FAN Y, PIVA R, et al. Sphase kinaseassociated protein 2 expression in nonHodgkin’s lymphoma inversely correlates with p27 expression and defines cells in S phase[J]. Am J Pathol,2002,160(4):14571466.
|
17. |
MAMILLAPALLI R, GAVRILOVA N, MIHAYLOVA VT, et al. PTEN regulates the ubiquitindependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2) [J]. Curr Biol,2001,11(4):263267.
|
18. |
PRUITT K, DER CJ. Ras and Rho regulation of the cell cycle and oncogenesis[J]. Cancer Lett,2001,171(1):110.
|
19. |
HURTEAU JA, ALLISON, BM, BRUTKIEWICZ SA, et al. Expression and subcellular localization of the cyclindependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer[J]. Gynecol Oncol,2001,83(2):292298.
|
20. |
LIN Z, LIM S, LIM MS. Growth regulation by p27Kip1 is abrogated by multiple mechanisms in aggressive malignant lymphomas[J]. Br J Haematol,2003,121(5):739748.
|
21. |
FILIPITS M, JAEGER U, POHL G, et al. Cyclin D3 is a predictive and prognostic factor in diffuse large Bcell lymphoma[J]. Clin Cancer Res,2002,8(3):729733.
|
22. |
程纯,邵晓轶,沈爱国,等.Cyclin D3与淋巴细胞增殖相关性的初步研究[J].中国免疫学杂志,2005,21(9):666669,673 .
|